Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP772622.RAcP43MyHZgmNczi7_q9_r22NbG3wiG9aBLxA3H7A13ts130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP772622.RAcP43MyHZgmNczi7_q9_r22NbG3wiG9aBLxA3H7A13ts130_assertion type Assertion NP772622.RAcP43MyHZgmNczi7_q9_r22NbG3wiG9aBLxA3H7A13ts130_head.
- NP772622.RAcP43MyHZgmNczi7_q9_r22NbG3wiG9aBLxA3H7A13ts130_assertion description "[We examined the effects of the mammalian target of rapamycin inhibitor, rapamycin, on mammary tumorigenesis in transgenic mice bearing an activated ErbB2 (NeuYD) transgene in the absence or presence of a second transgene encoding vascular endothelial growth factor (VEGF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772622.RAcP43MyHZgmNczi7_q9_r22NbG3wiG9aBLxA3H7A13ts130_provenance.
- NP772622.RAcP43MyHZgmNczi7_q9_r22NbG3wiG9aBLxA3H7A13ts130_assertion evidence source_evidence_literature NP772622.RAcP43MyHZgmNczi7_q9_r22NbG3wiG9aBLxA3H7A13ts130_provenance.
- NP772622.RAcP43MyHZgmNczi7_q9_r22NbG3wiG9aBLxA3H7A13ts130_assertion SIO_000772 15958580 NP772622.RAcP43MyHZgmNczi7_q9_r22NbG3wiG9aBLxA3H7A13ts130_provenance.
- NP772622.RAcP43MyHZgmNczi7_q9_r22NbG3wiG9aBLxA3H7A13ts130_assertion wasDerivedFrom befree-20150227 NP772622.RAcP43MyHZgmNczi7_q9_r22NbG3wiG9aBLxA3H7A13ts130_provenance.
- NP772622.RAcP43MyHZgmNczi7_q9_r22NbG3wiG9aBLxA3H7A13ts130_assertion wasGeneratedBy ECO_0000203 NP772622.RAcP43MyHZgmNczi7_q9_r22NbG3wiG9aBLxA3H7A13ts130_provenance.